Back to News

³Ô¹Ï±¬ÁÏ Summit Previews Falcon and the Path to Agentic Biopharma

More than 2,000 gathered to see the future of industry AI

AOP Health, Boehringer Ingelheim, GSK, Haleon, MSD, Novo Nordisk, Roche, Sanofi, and Sobi among leaders sharing strategies to streamline and connect operations

BARCELONA, Spain ¡ª 4 June 2026 ¡ª At the recent ³Ô¹Ï±¬ÁÏ R&D and Quality Summit Europe held on 28-29 May in Copenhagen, Denmark, ³Ô¹Ï±¬ÁÏ Systems (NYSE: VEEV) showcased its upcoming ³Ô¹Ï±¬ÁÏ Falcon agentic labor platform and new Vault AI innovations. Leaders from across the industry ¡ª including AOP Health, Boehringer Ingelheim, GSK, MSD, Novo Nordisk, Roche, and Sanofi ¡ª shared their successes and how they are simplifying and standardizing operations and establishing a scalable path for AI.

³Ô¹Ï±¬ÁÏ shared Vault AI Agents available today and the planned release of Vault AI across all Vault applications in August 2026. The company also previewed ³Ô¹Ï±¬ÁÏ Falcon agentic labor to reduce cost, increase speed, and maintain compliance in drug development. Planned for early adopters in late 2026, Falcon agentic labor will initially focus on trial master file document intake and quality control, health authority correspondence in regulatory, and safety case triage and intake.

The event brought together over 2,000 clinical, regulatory, safety, and quality leaders for more than 100 sessions. Insights shared included:

Accelerating development and manufacturing with connected clinical, regulatory, and quality

  • AOP Health speeding development to delivery with connected R&D, quality, commercial, and data on ³Ô¹Ï±¬ÁÏ Industry Cloud

Advancing clinical and site collaboration with unified data

  • Boehringer Ingelheim¡¯s end-to-end clinical operations to connect with sites and patients
  • GSK standardizing site engagement for faster activation and improved performance
  • Boehringer Ingelheim and Roche streamlining site payments and strengthening site collaboration
  • Novo Nordisk, Sobi, and Syneos Health Consulting gaining full data ownership and clinical efficiency by connecting EDC to the clinical database

Modernizing quality, safety, and compliance for increased productivity

  • Haleon and Sanofi preparing for agentic AI in quality that prioritizes efficiency gains
  • Novo Nordisk simplifying pharmacovigilance to improve efficiency and global data management
  • UCB modernizing system validation to support GxP readiness and continuous compliance

¡°The ideas shared and connections made at ³Ô¹Ï±¬ÁÏ Summit will extend far beyond the event to move the industry to an agentic future,¡± said Rik van Mol, senior vice president, ³Ô¹Ï±¬ÁÏ Development Cloud. ¡°Vault AI and ³Ô¹Ï±¬ÁÏ Falcon are a significant step in AI-enabling life sciences for greater speed and efficiency.¡±

Learn more about ³Ô¹Ï±¬ÁÏ Falcon agentic labor, Vault AI, and other core Vault innovations through session replays on .

About ³Ô¹Ï±¬ÁÏ Systems
³Ô¹Ï±¬ÁÏ delivers the industry cloud for life sciences with software, AI, data, and consulting. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

³Ô¹Ï±¬ÁÏ Forward-Looking Statements
This release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ¡¯s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the fiscal year ended January 31, 2026, which you can find (a summary of risks which may impact our business can be found on pages 13 and 14), and in our subsequent SEC filings, which you can access at .

###

Contact:

Jeremy Whittaker
³Ô¹Ï±¬ÁÏ Systems
+49-695-095-5486
jeremy.whittaker@veeva.com

Meera Lakhani-Patel
³Ô¹Ï±¬ÁÏ Systems
+44-790-430-0698
meera.lakhani-patel@veeva.com

³Ô¹Ï±¬ÁÏ Commercial Summit, Europe

Copenhagen | 18¨C19 November, 2026

Register Now